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CLINICAL CASE

AUTOLOGOUS SERUM IN VASCULAR ULCER OF LONG
EVOLUTION
SUERO AUTÓLOGO EN ÚLCERA VASCULAR DE LARGA EVOLUCIÓN
Germán V. M. Rossani1,2,a, Rafael I. Hernández Patiño1,2,a

ABSTRACT
The treatment of chronic wounds continues to be a topic of great interest due to the slow evolution and
difficult healing they present, despite the development of new therapies on wound care and treatment.

CLINICAL CASE

We present the case of a 76 year old male patient with a chronic vascular ulcer, 3 years of evolution,
located in the distal portion of the left leg, with severe incompetence of saphenous vein minor to
predominance of left lower limb. Who receives as treatment the application of autologous serum,
achieving epithelialization and subsequent healing of the lesion.
Key words: Autologous serum; Vascular ulcers; Scarring (source: MeSH NLM).

RESUMEN
El tratamiento de las heridas crónicas sigue siendo un tema de gran interés debido a la evolución lenta
y la difícil cicatrización que presentan, a pesar del desarrollo de nuevas terapias sobre el cuidado y
tratamiento de las heridas.
Se presenta el caso de un paciente varón, de 76 años con una ulcera vascular crónica, de 3 años de
evolución, localizada en la porción distal de la pierna izquierda, con severa incompetencia de vena safena
menor a predominio de miembro inferior izquierdo. Quien recibe como tratamiento la aplicación de
suero autologo, logrando la epitelizacion y posterior cicatrización de la lesión.
Palabras clave: Suero autologo; Ulceras vasculares; Cicatrización (fuente: DeCS BIREME).

INTRODUCTION
The treatment of chronic wounds continues to be
a topic of great interest, despite the development
of new therapies for the care and management of
wounds that are difficult to resolve, due to the slow
or prolonged injuries healing evolution.
Lesions of vascular origin are generally associated
with diabetic patients, who usually have a
recurrence up to five years in 70% of cases(1). It
represents an important cause of morbidity in
the world due to its tendency to chronicity, even
reaching the amputation of the limb.

Vascular lesions in non-diabetic patients,
characterized by significant alterations in
the peripheral and deep blood circulation,
also represent a serious problem due to their
predisposition to infections, which is related to
the severity of the ulcer(2). This situation leads to
recurrent hospitalizations, and in some cases long
periods of absence from work, which entails high
costs for hospital economic costs and have a direct
impact on quality of life(3).
A series of studies have been carried out on growth
factors, achieving a certain consensus on the
benefit they provide by efficiently reducing repair
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time and wound healing(2).
However, questions arise in the medical community
about how to predict the proper ratio between
the different factors involved in the repair process.
Currently, some growth factors have been isolated,
but these are not yet available to the entire
population, unlike autologous serum(2).

CLINICAL CASE

In this clinical case, the autologous serum obtained
from whole blood with calcium citrate was used,
which was centrifuged at 3,500 rpm in 8 minutes
and all of the autologous serum was separated.
This was activated with 10% calcium chloride, and
covered with paraffin gauze dressing and gauze. This
protocol was repeated with intervals of 4 days(4).
The application shows an activation of the initial
healing within the first 24 hours, where it is observed
how the dermal buttons begin to be stimulated,
which are replacing the initial scar tissue by noble
tissue.

CASE REPORT
A 76-year-old male patient, retired, from Huari
(home town) and Lima. As a pathological history, he
presented a left hip prosthesis due to osteoarthritis,
with a 10-year evolution time. His disease began
3 years ago, initially presenting a dermal lesion
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type phlyctena in the internal malleolus of the
left foot. It went through intermittent stages of
exacerbation, modifying its appearance and size,
with an intermittent positive response to clinical
management of antibiotic therapy (oral route)
and topical treatment (regenerative creams). On
occasions, hospitalization was carried out to expand
the study of the patient, clinical management, and
antibiotic therapy (intravenously), performing daily
cures with biological dressings to control the extent
of the lesion.
He arrives at our service, presenting an injury
in the distal region of his left leg. Oral antibiotic
management was performed with ciprofloxacin
500mg every 12 hours and paracetamol 500mg every
eight hours, but without apparent improvement
during the last month. (view photos).
Physical examination revealed a lesion measuring
approximately 10x15 cm, extending from the medial
malleolus to the external malleolus in a surrounding
manner. It is covered with a hydrocolloid dressing,
with 80% granulation tissue, serohematic secretion,
signs of maceration and foul odor, irregular
borders, erythema and surrounding edema. Distal
pulse present and pain of 5/10 according to visual
analogue scale.

C

Figure 1. 24 hours after starting therapy, where an immediate response to the initial healing process is

observed. A) View of the inner of the left leg B) Anterior view of the distal portion of the left leg, and C) View
of the outer of the left leg.
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In auxiliary examination: hemoglobin of 13 mg/dL,
sedimentation rate of 20 mm/h, C-reactive protein
of 1.76 mg/L, glucose 105 mg/dL, creatinine 1.60
mg/dL. Secretion culture of the sample positive to
S. aureus, resistant to ciprofloxacin and sensitive to
clindamycin.
Treatment with clindamycin 300 mg every eight
hours is started and a first cleaning of the affected
area was performed with Isodine foam and solution,

Later sodium chloride is applied to the bloody bed,
it is covered with autologous serum gauze topically
and paraffin gauze; occlusive closure is performed
for 24 hours.
At 24 hours, the occlusive patch was opened and a
reduction of the bloody bed was evidenced, areas
with the presence of macerated tissue and a velvety
appearance, with the appearance of dermal buttons
(view photo).

CLINICAL CASE

A

B

C

Figure 2. 24 hours after starting therapy, where an immediate response to the initial healing process is

observed. A) View of the inner of the left leg B) Anterior view of the distal portion of the left leg, and C) View
of the outer of the left leg.

Figure 3. Photograph 48 hours after starting therapy, where a reduction of the affected area is appreciated,
with decreased secretion, erythema and surrounding edema.
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Figure 4. Photograph of the initial healing progress 7 days after starting the treatment, where residual
areas of lesion in progress of resolution can be seen, with epithelialization areas.

The lesion progresses favorably until the 4th week,
obtaining 95% healing and leaving a residual lesion
in the internal malleolus region with characteristics
similar to those described in the initial process 3
years ago, without further progress.

A venous Doppler exam was performed, finding
severe incompetence of the small saphenous
vein, with slight incompetence of the distal great
saphenous vein, perforating and accessory veins.
We proceeded to the specialist to perform a surgical
correction of the vascular lesion.

Figure 5. Residual lesion in the internal malleolus of the left leg. Doppler ultrasound showing incompetence

of the small saphenous vein, with slight incompetence of the distal great saphenous vein, perforating and
accessory veins.
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CLINICAL CASE

Figure 6. After 3 months of treatment, a scarring of the vascular ulcer is observed.
A total closure of the lesion is achieved after 3 months
from the start of treatment with the autologous
serum.

DISCUSSION
Chronic vascular lesions become a vicious circle due to
their ease of contamination, a process characterized
by an excessive increase in the production of proinflammatory cytokines and proteolytic enzymes.
This causes an alteration in the pH of the affected
area, making the repair and healing process difficult.
In general, patients with chronic vascular lesions are
usually cared for in a conventional way, receiving
antibiotic/antimicrobial treatment for 2 weeks, daily
topical dressings and covered with hydrogels or
foams that allow exudate control until the elimination
of the infection, improving the conditions of injury.
Autologous serum is used as an alternative therapy
in the absence of response to conventional
treatment, in order to help restore the inactivity of
growth factors(5). This massive release of proteins 5-8
times their physiological concentration, secreted by
platelets, exerts its action to promote repair(5).
Monton E, et al., presented a retrospective study
of clinical practice (vascular ulcers, diabetic feet,
radiopathies, loss of substance, complex cases and
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reconstruction). In this study, 151 patients were
evaluated, of whom 47 received another type of
treatment for a period of 30 months, using plateletrich plasma (PRP) in chronic wounds with 6 months
of treatment(6). A significant, although not significant,
reduction in the time to healing was obtained
in patients treated with PRP (mean 2.6 months)
compared to the previous time (11.9 months). This
improvement was achieved in 72% of the patients (n
= 108) through a single application of PRP, alone or
in combination(6).
Several cases were reported where the evolution of
reparative phenomena were absent or appeared for
very long periods of time (23 years in one reported
case), and in which multiple reparative procedures
had failed. Very favorable results were obtained
from the point of view of the efficacy of cures after
therapies based on clinical observation of the
evolution of the reparative process(6).
The use of autologous serum is a therapy that is
increasingly used in clinical practice in different
specialties due to the benefits it provides in
accelerating tissue repair processes. To date, no
adverse reactions have been reported; this probably
because it is easy to extract and manipulate under
established protocols. In addition, it is a therapy that
reduces hospital costs that usually cause this type of
chronic injury.
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